Latest updates for Glvax
Fresh curated links around GLVAX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Invesco Global Focus Fund Q4 2025 Commentary
- Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
- GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marbu
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
finance.yahoo.com
/1 month ago
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
seekingalpha.com
/2 days ago
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marbu...
seekingalpha.com
/1 month ago
CGGO: Global ETF With Strong Fundamentals And Average Returns
seekingalpha.com
/2 days ago
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
cafepharma.com
/4 days ago
May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion
May 26 2026 - Lilly to acquire three vaccine developers for nearly $4 billion admin Tue, 05/26/2026 - 11:55 Lilly keeps pushing forward with deals and pipeline mome...
seekingalpha.com
/1 month ago
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerostomia and Commercial...
cafepharma.com
/8 hours ago
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
cafepharma.com
/1 month ago
INVIVYD
INVIVYD Anonymous (not verified) Wed, 04/29/2026 - 14:17 field_thread_url https://cafepharma.com/boards/threads/invivyd.703943/ board na...
seekingalpha.com
/1 month ago
OVL: Your Chance To Outperform The S&P While Collecting A 10% Yield
seekingalpha.com
/4 weeks ago
Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market
seekingalpha.com
/1 week ago
argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System
fool.com
/2 weeks ago
Invivyd (IVVD) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateMay 14, 2026 at 8:30 a.m. ETCall participantsChairman of the Board — Marc EliaChief Medical Officer — Dr. Michael MinaChief Scientific Officer —...
fool.com
/2 weeks ago
Invivyd (IVVD) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DateMay 14, 2026 at 8:30 a.m. ETCall participantsChairman of the Board — Marc EliaChief Medical Officer — Dr. Michael MinaChief Scientific Officer —...
seekingalpha.com
/1 month ago
Inovio Pharmaceuticals, Inc. (INO) Presents at World Federation of Hemophilia World Congress - Slideshow
seekingalpha.com
/10 hours ago
Pharvaris N.V. (PHVS) Presents at The 2026 Eastern Allergy Conference - Slideshow
seekingalpha.com
/2 weeks ago
Immuneering Corporation: Updates Inbound At The End Of The Month
seekingalpha.com
/4 weeks ago
Telix Pharmaceuticals Limited (TLX) Discusses Advances in PSMA Therapy and Insights from the OPTIMAL-PSMA Trial with TLX...
jdsupra.com
/2 weeks ago
Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee®...
Insulin Glargine Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims fro...
jdsupra.com
/1 month ago
Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee®...
Insulin Glargine Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims fro...
seekingalpha.com
/2 weeks ago
MoonLake Immunotherapeutics GAAP EPS of -$0.98 misses by $0.07
seekingalpha.com
/9 hours ago
Vir Biotechnology, Inc. (VIR) Presents at EASL Congress 2026 - Slideshow
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Glvax
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source